Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie

29. Décembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3739


	Articles 1 - 20 / 74777

	m5C-Related Regulators Define Tumor Microenvironment and Predict Prognosis in Hepatocellular Carcinoma. Asian Pac J Cancer Prev Gu XQ, Li B, Gu CY, Wu MY, Wang N. PMID: 41459880 [PubMed - indexed for MEDLINE]
	Unraveling Key Regulatory Pathways in Non-HCV-Induced Hepatocellular Carcinoma: Insights from Exclusively Mutated Genes and Prognostic Biomarkers. Asian Pac J Cancer Prev Khalifa MK, Hmed AA, Elfeky KS, Bakry S, Elhamshary MO, Sofy AR. PMID: 41459874 [PubMed - indexed for MEDLINE]
	GLI1-Altered Mesenchymal Tumor of the Duodenum With a Novel TNFAIP3::GLI1 Gene Fusion: Report of a Diagnostically Challenging Case Associated With Late Metastasis. Genes Chromosomes Cancer Argani P, Fang H, Liu YJ, Baraban E, Gross JM. PMID: 41459684 [PubMed - indexed for MEDLINE]
	Prognostic significance of reduced handgrip strength in patients with unresectable hepatocellular carcinoma receiving HAIC combined with targeted immunotherapy. Front Immunol Wang XZ, Wang P, Lv X, Zhang ZL, Zhang EL, Ji GB. PMID: 41459515 [PubMed - indexed for MEDLINE]
	The Role of RANBP3L in Pan-Cancer With Its Significance in Hepatocellular Carcinoma. Cancer Rep (Hoboken) Cen B, Li J, Wang C. PMID: 41457788 [PubMed - indexed for MEDLINE]
	Mixed U-Net: Segmentation of focal liver lesions using a hybrid 2D and 3D model. J Appl Clin Med Phys Gao F, Hu Z, Xian J, Lu W. PMID: 41456602 [PubMed - indexed for MEDLINE]
	A therapeutic approach of LC-MS characterised MFER-Mc against alcohol and NDEA induced hepatocellular carcinoma activity through LXR-Î±, LXR-Î² and HMG-CoA pathway: an in-silico, in-vitro and in-vivo study. Med Oncol Ranjan S, Sunita P, Pattanayak SP. PMID: 41455855 [PubMed - indexed for MEDLINE]
	Primary hepatic follicular dendritic cell sarcoma: A case study and literature review. J Int Med Res Zhu J, Liang Y, Zhang L, Li B, Zheng D, Wang H. PMID: 41454748 [PubMed - indexed for MEDLINE]
	A Novel MPT-Driven Necrosis-Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using Organoids. Cancer Med Liu Y, Tao L, Shen Z, Zheng J, Wang Y, Chen M, Xie Y, Chen H, Cai J, Pan H, Li S, Jin R, Xu J, Liang X. PMID: 41454619 [PubMed - indexed for MEDLINE]
	Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions. Ann Med Song R, Li M, Tang S, Zhang G. PMID: 41454610 [PubMed - indexed for MEDLINE]
	Nanovaccines in hepatocellular carcinoma: a new frontier in cancer immunotherapy. Med Oncol Usmani A, Siddiqui MA, Mishra A, Almoselhy RIM, Shoaib A, Gobinath M, Ansari MN. PMID: 41452547 [PubMed - indexed for MEDLINE]
	Ethical challenges and governance of artificial intelligence in hepatocellular carcinoma management : Wan DL et al. Ethical considerations in AI for hepatocellular carcinoma. Med Oncol Wan DL, Lin SZ. PMID: 41452505 [PubMed - indexed for MEDLINE]
	Therapeutic potential of natural triterpenoids in liver cancer. Med Oncol Niu C, Zhang J, Okolo Iii PI. PMID: 41452426 [PubMed - indexed for MEDLINE]
	Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study. Liver Int Kim JS, Wong J, Chen SC, Tai D, Yang H, Kim Y, Kang B, Kim I, Kim H, An C, Jang SJ, Kudo M, Lim HY, Kim C, Yau T, Chon HJ. PMID: 41451780 [PubMed - indexed for MEDLINE]
	Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden. Front Immunol Guan MC, Li N, Ding Q, Sun D, Li H, Yang M, Hong L, Zhu H. PMID: 41451207 [PubMed - indexed for MEDLINE]
	Circular RNA in hepatocellular carcinoma: emerging therapeutic strategies. Front Immunol Jazbec G, Re. PMID: 41445747 [PubMed - indexed for MEDLINE]
	Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Curr Oncol Minamiguchi K, Irizato M, Nakano R, Kunichika H, Tachiiri T, Taiji R, Tsuji Y, Yasuda S, Yoshiji H, Sho M, Tanaka T. PMID: 41440222 [PubMed - indexed for MEDLINE]
	Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma. Curr Oncol Ye G, Zhang H, Feng Q, Xiao J, Wang J, Liu J. PMID: 41440201 [PubMed - indexed for MEDLINE]
	Hepatoblastoma Cell Lines: Past, Present and Future. Cells Prochownik EV, Henchy CM, Wang H. PMID: 41440033 [PubMed - indexed for MEDLINE]
	Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments. Front Immunol Yadav DK, Yadav RK, Singh A, Huang Y, Bao D, Yang Z, Huang H, Jiang Y, Wang P, Lin S, Hua Y, Hu Y. PMID: 41438763 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 74777

Page 1 de 3739



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité